- Home
- NTAP vs ROIV Comparison
NTAP vs ROIV Comparison
Compare NTAP & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTAP | ROIV |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5B | 20.7B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NTAP | ROIV |
|---|---|---|
| Price | $110.85 | $28.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $116.58 | $28.94 |
| AVG Volume (30 Days) | 1.8M | ★ 4.4M |
| Earning Date | 05-28-2026 | 05-28-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | ★ 22.46 | N/A |
| EPS | ★ 4.32 | N/A |
| Revenue | ★ $6,233,200,000.00 | $29,053,000.00 |
| Revenue This Year | $6.22 | N/A |
| Revenue Next Year | $4.91 | $744.61 |
| P/E Ratio | $25.91 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $91.15 | $10.58 |
| 52 Week High | $126.66 | $30.33 |
Technical Indicators
Market Signals| Indicator | NTAP | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 63.27 | 50.05 |
| Support Level | $106.74 | $27.00 |
| Resistance Level | $113.78 | $30.26 |
| Average True Range (ATR) | 3.13 | 0.91 |
| MACD | 0.55 | -0.11 |
| Stochastic Oscillator | 81.60 | 37.02 |
Price Performance
Historical ComparisonAbout NTAP NetApp Inc.
NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of the cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services. Geographically, the company generates the majority of its revenue from the United States, Canada and Latin America (Americas).
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.